Media Mentions
2010
“HHS Will Not Renew SACGHS Charter, Ending Committee's Decade-Long Tenure in October”
Genomeweb.com, September 23, 2010
Sheila Walcoff was quoted regarding the charter expiration and final meeting of the HHS Secretary's Advisory Committee on Genetics, Health, & Society, which was created in 2002 to address topics critical to the advancement and adoption of genetic technologies and information. As a member of the Committee, Ms. Walcoff stated: "I believe it has advanced the debate on key issues related to genomics and personalized medicine that will influence the development of the future of health care and research in a meaningful way."
, Health
Shelia Walcoff was mentioned by The Hill (June 21) as new lobbyist for the Diabetes Access to Care Coalition with regard to the Medicare medical equipment supplies competitive bidding program.
, Government Strategies, Health
Sheila Walcoff was quoted by The National Law Journal on March 15 concerning provisions in the health reform bill that will give the Food & Drug Administration (FDA) new powers to approve generic biologic drugs, called biosimilars. She noted that the difficulty in making a biosimilar is akin to exactly copying a chicken soup recipe – “you’re working with a natural source, and every chicken is different.” For that reason, Ms. Walcoff said, “The most important issue is determining what level of clinical evidence will be necessary to give confidence to consumers that a product is safe and effective. The FDA has already given it a lot of thought,” she added. “The career staff are going to want to make sure they are exactly right on the science given the level of congressional interest in drug safety.”
, Health
2009
Shelia Walcoff is quoted in a September 30 Genomeweb.com story concerning a California bill seeking to legally set apart consumer genomics firms from clinical laboratories. Ms. Walcoff believes that the language in SB 420 could have implications for the bioinformatics field. As she noted, consumer genomics “is a new industry, and should California statutorily define and regulate it in a new or different manner, it could, at least at the state level, have an unanticipated impact on the regulatory requirements for the broader bioinformatics industry.”
, Government Strategies, Life Sciences & Medical Products
Robert Nicholas and Sheila Walcoff's article, "President Obama Announces FDA Commissioner and Deputy Commissioner Appointments" was mentioned in a March 17 story by Dickinson's FDA Webview.
, Health, Life Sciences & Medical Products, Life Sciences - Health
2008
Sheila D. Walcoff was mentioned in the July 18 issue of the Sarasota Herald-Tribune regarding her recent move as partner in the Health Law Department of McDermott's Washington, D.C. office.
, Health
